Editorial: International Classification of Headache Disorders, 3rd Edition, beta version

Authors


  • Conflict of Interest: Grants/research support (no personal compensation, all paid to Cleveland Clinic, and not tied to salary): ATI, GSK, MAP, Merck, OptiNose. All personal compensation <$10,000 per company: consultant: Allergan, ATI, Impax, Merck, Nautilus, NuPathe, Zogenix; speakers bureau: Allergan, ATI, Impax, Merck, Nautilus, Zogenix; advisors board: Allergan, ATI, Merck, Nautilus, NuPathe, Pfizer, USWorldMeds, Zogenix; stock options: ATI. Royalties from books: University of Mississippi Press, Peoples Publishing House of Peking, Springer.

Address all correspondence to S.J. Tepper, Headache Center, C21, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA, email: teppers@ccf.org.

No abstract is available for this article.

Ancillary